NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
25 hedge funds and large institutions have $65.3M invested in NKGen Biotech, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.64M | |
| 2 | +$2.6M | |
| 3 | +$1.09M | |
| 4 |
Walleye Capital
New York
|
+$207K |
| 5 |
VF
Virtu Financial
New York
|
+$127K |
Top Sellers
| 1 | -$13.7M | |
| 2 | -$8.94M | |
| 3 | -$8.17M | |
| 4 |
CIM
Cowen Investment Management
New York
|
-$7.6M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.12M |